What is the current valuation of the Poultry Diagnostics Market as of 2024?

The Poultry Diagnostics Market was valued at 3.811 USD Billion in 2024. Read More

What is the projected market size for the Poultry Diagnostics Market in 2035?

The market is projected to reach 7.32 USD Billion by 2035. Read More

What is the expected CAGR for the Poultry Diagnostics Market during the forecast period 2025 - 2035?

The expected CAGR for the Poultry Diagnostics Market during 2025 - 2035 is 6.11%. Read More

Which technology segment is anticipated to show significant growth in the Poultry Diagnostics Market?

Molecular Diagnostics is expected to grow from 1.1 USD Billion in 2024 to 2.1 USD Billion by 2035. Read More

How does the market for poultry diagnostics differ by poultry type?

The market for Chickens is projected to grow from 1.5 USD Billion in 2024 to 2.8 USD Billion by 2035. Read More

What are the key disease types driving the Poultry Diagnostics Market?

Infectious Diseases are expected to increase from 1.5 USD Billion in 2024 to 2.8 USD Billion by 2035. Read More

Who are the leading companies in the Poultry Diagnostics Market?

Key players include Zoetis, Merck Animal Health, and IDEXX Laboratories, among others. Read More

What is the expected growth for the Commercial Poultry Farms segment?

The Commercial Poultry Farms segment is projected to grow from 1.5 USD Billion in 2024 to 3.0 USD Billion by 2035. Read More

How does the market for diagnostics laboratories compare to other end users?

Diagnostics Laboratories are expected to grow from 0.9 USD Billion in 2024 to 1.8 USD Billion by 2035. Read More

What role do handheld devices play in the Poultry Diagnostics Market?

Handheld Devices are anticipated to increase from 0.25 USD Billion in 2024 to 0.5 USD Billion by 2035. Read More

Poultry Diagnostics Market

ID: MRFR/MED/27696-HCR

128 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Poultry Diagnostics Market Research Report By Technology (Serology, Molecular Diagnostics, Microbiology, Histopathology, Immunoassays, Molecular Diagnostics, Sample Preparation, Handheld Devices), By Poultry Type (Chickens, Ducks, Geese, Turkeys, Other Poultry), By Disease Type (Infectious Diseases, Non-Infectious Diseases, Metabolic Diseases, Reproductive Diseases), By End User (Commercial Poultry Farms, Diagnostics Laboratories, Veterinary Hospitals and Clinics, Research Institutes) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Technology (USD Billion)
4.1.1 Serology
4.1.2 Molecular Diagnostics
4.1.3 Microbiology
4.1.4 Histopathology
4.1.5 Immunoassays
4.1.6 Sample Preparation
4.1.7 Handheld Devices
4.2 Healthcare, BY Poultry Type (USD Billion)
4.2.1 Chickens
4.2.2 Ducks
4.2.3 Geese
4.2.4 Turkeys
4.2.5 Other Poultry
4.3 Healthcare, BY Disease Type (USD Billion)
4.3.1 Infectious Diseases
4.3.2 Non-Infectious Diseases
4.3.3 Metabolic Diseases
4.3.4 Reproductive Diseases
4.4 Healthcare, BY End User (USD Billion)
4.4.1 Commercial Poultry Farms
4.4.2 Diagnostics Laboratories
4.4.3 Veterinary Hospitals and Clinics
4.4.4 Research Institutes
4.5 Healthcare, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Zoetis (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Merck Animal Health (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 IDEXX Laboratories (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Neogen Corporation (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Boehringer Ingelheim (DE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Thermo Fisher Scientific (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Heska Corporation (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Virbac (FR)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Cegelec (FR)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY TECHNOLOGY
6.4 US MARKET ANALYSIS BY POULTRY TYPE
6.5 US MARKET ANALYSIS BY DISEASE TYPE
6.6 US MARKET ANALYSIS BY END USER
6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY
6.8 CANADA MARKET ANALYSIS BY POULTRY TYPE
6.9 CANADA MARKET ANALYSIS BY DISEASE TYPE
6.10 CANADA MARKET ANALYSIS BY END USER
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY
6.13 GERMANY MARKET ANALYSIS BY POULTRY TYPE
6.14 GERMANY MARKET ANALYSIS BY DISEASE TYPE
6.15 GERMANY MARKET ANALYSIS BY END USER
6.16 UK MARKET ANALYSIS BY TECHNOLOGY
6.17 UK MARKET ANALYSIS BY POULTRY TYPE
6.18 UK MARKET ANALYSIS BY DISEASE TYPE
6.19 UK MARKET ANALYSIS BY END USER
6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY
6.21 FRANCE MARKET ANALYSIS BY POULTRY TYPE
6.22 FRANCE MARKET ANALYSIS BY DISEASE TYPE
6.23 FRANCE MARKET ANALYSIS BY END USER
6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
6.25 RUSSIA MARKET ANALYSIS BY POULTRY TYPE
6.26 RUSSIA MARKET ANALYSIS BY DISEASE TYPE
6.27 RUSSIA MARKET ANALYSIS BY END USER
6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY
6.29 ITALY MARKET ANALYSIS BY POULTRY TYPE
6.30 ITALY MARKET ANALYSIS BY DISEASE TYPE
6.31 ITALY MARKET ANALYSIS BY END USER
6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY
6.33 SPAIN MARKET ANALYSIS BY POULTRY TYPE
6.34 SPAIN MARKET ANALYSIS BY DISEASE TYPE
6.35 SPAIN MARKET ANALYSIS BY END USER
6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
6.37 REST OF EUROPE MARKET ANALYSIS BY POULTRY TYPE
6.38 REST OF EUROPE MARKET ANALYSIS BY DISEASE TYPE
6.39 REST OF EUROPE MARKET ANALYSIS BY END USER
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY
6.42 CHINA MARKET ANALYSIS BY POULTRY TYPE
6.43 CHINA MARKET ANALYSIS BY DISEASE TYPE
6.44 CHINA MARKET ANALYSIS BY END USER
6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY
6.46 INDIA MARKET ANALYSIS BY POULTRY TYPE
6.47 INDIA MARKET ANALYSIS BY DISEASE TYPE
6.48 INDIA MARKET ANALYSIS BY END USER
6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY
6.50 JAPAN MARKET ANALYSIS BY POULTRY TYPE
6.51 JAPAN MARKET ANALYSIS BY DISEASE TYPE
6.52 JAPAN MARKET ANALYSIS BY END USER
6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
6.54 SOUTH KOREA MARKET ANALYSIS BY POULTRY TYPE
6.55 SOUTH KOREA MARKET ANALYSIS BY DISEASE TYPE
6.56 SOUTH KOREA MARKET ANALYSIS BY END USER
6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
6.58 MALAYSIA MARKET ANALYSIS BY POULTRY TYPE
6.59 MALAYSIA MARKET ANALYSIS BY DISEASE TYPE
6.60 MALAYSIA MARKET ANALYSIS BY END USER
6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY
6.62 THAILAND MARKET ANALYSIS BY POULTRY TYPE
6.63 THAILAND MARKET ANALYSIS BY DISEASE TYPE
6.64 THAILAND MARKET ANALYSIS BY END USER
6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
6.66 INDONESIA MARKET ANALYSIS BY POULTRY TYPE
6.67 INDONESIA MARKET ANALYSIS BY DISEASE TYPE
6.68 INDONESIA MARKET ANALYSIS BY END USER
6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
6.70 REST OF APAC MARKET ANALYSIS BY POULTRY TYPE
6.71 REST OF APAC MARKET ANALYSIS BY DISEASE TYPE
6.72 REST OF APAC MARKET ANALYSIS BY END USER
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
6.75 BRAZIL MARKET ANALYSIS BY POULTRY TYPE
6.76 BRAZIL MARKET ANALYSIS BY DISEASE TYPE
6.77 BRAZIL MARKET ANALYSIS BY END USER
6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY
6.79 MEXICO MARKET ANALYSIS BY POULTRY TYPE
6.80 MEXICO MARKET ANALYSIS BY DISEASE TYPE
6.81 MEXICO MARKET ANALYSIS BY END USER
6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
6.83 ARGENTINA MARKET ANALYSIS BY POULTRY TYPE
6.84 ARGENTINA MARKET ANALYSIS BY DISEASE TYPE
6.85 ARGENTINA MARKET ANALYSIS BY END USER
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY POULTRY TYPE
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISEASE TYPE
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
6.92 GCC COUNTRIES MARKET ANALYSIS BY POULTRY TYPE
6.93 GCC COUNTRIES MARKET ANALYSIS BY DISEASE TYPE
6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER
6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
6.96 SOUTH AFRICA MARKET ANALYSIS BY POULTRY TYPE
6.97 SOUTH AFRICA MARKET ANALYSIS BY DISEASE TYPE
6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER
6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
6.100 REST OF MEA MARKET ANALYSIS BY POULTRY TYPE
6.101 REST OF MEA MARKET ANALYSIS BY DISEASE TYPE
6.102 REST OF MEA MARKET ANALYSIS BY END USER
6.103 KEY BUYING CRITERIA OF HEALTHCARE
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF HEALTHCARE
6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.111 HEALTHCARE, BY POULTRY TYPE, 2024 (% SHARE)
6.112 HEALTHCARE, BY POULTRY TYPE, 2024 TO 2035 (USD Billion)
6.113 HEALTHCARE, BY DISEASE TYPE, 2024 (% SHARE)
6.114 HEALTHCARE, BY DISEASE TYPE, 2024 TO 2035 (USD Billion)
6.115 HEALTHCARE, BY END USER, 2024 (% SHARE)
6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.2.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.2.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.2.4 BY END USER, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.3.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.3.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.3.4 BY END USER, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.4.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.4.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.4.4 BY END USER, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.5.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.5.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.5.4 BY END USER, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.6.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.6.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.6.4 BY END USER, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.7.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.7.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.7.4 BY END USER, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.8.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.8.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.8.4 BY END USER, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.9.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.9.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.9.4 BY END USER, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.10.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.10.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.10.4 BY END USER, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.11.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.11.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.11.4 BY END USER, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.12.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.12.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.12.4 BY END USER, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.13.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.13.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.13.4 BY END USER, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.14.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.14.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.14.4 BY END USER, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.15.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.15.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.15.4 BY END USER, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.16.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.16.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.16.4 BY END USER, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.17.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.17.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.17.4 BY END USER, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.18.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.18.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.18.4 BY END USER, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.19.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.19.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.19.4 BY END USER, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.20.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.20.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.20.4 BY END USER, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.21.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.21.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.21.4 BY END USER, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.22.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.22.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.22.4 BY END USER, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.23.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.23.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.23.4 BY END USER, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.24.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.24.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.24.4 BY END USER, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.25.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.25.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.25.4 BY END USER, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.26.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.26.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.26.4 BY END USER, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.27.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.27.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.27.4 BY END USER, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.28.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.28.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.28.4 BY END USER, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.29.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.29.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.29.4 BY END USER, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
7.30.2 BY POULTRY TYPE, 2025-2035 (USD Billion)
7.30.3 BY DISEASE TYPE, 2025-2035 (USD Billion)
7.30.4 BY END USER, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Technology (USD Billion, 2025-2035)

Serology
Molecular Diagnostics
Microbiology
Histopathology
Immunoassays
Sample Preparation
Handheld Devices

Healthcare By Poultry Type (USD Billion, 2025-2035)

Chickens
Ducks
Geese
Turkeys
Other Poultry

Healthcare By Disease Type (USD Billion, 2025-2035)

Infectious Diseases
Non-Infectious Diseases
Metabolic Diseases
Reproductive Diseases

Healthcare By End User (USD Billion, 2025-2035)

Commercial Poultry Farms
Diagnostics Laboratories
Veterinary Hospitals and Clinics
Research Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓